Ther Clin Risk Manag Volume 2(1); March 2006

Other Issues: previous | next | latest | archive

Volume 2(1); March 2006

Editorial Foreword

EDITORIAL FOREWORD

Garry Walsh

Ther Clin Risk Manag. 2006 March; 2(1): 1–2. Published online 2006 March.

PMCID: PMC1661650

| Full Text | PDF–33K |

Reviews

Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis

Frieder Bauss and Ralph C Schimmer

Ther Clin Risk Manag. 2006 March; 2(1): 3–18. Published online 2006 March.

PMCID: PMC1661644

| Abstract | Full Text | PDF–182K |

Oxybutynin: an overview of the available formulations

Rebecca J McCrery and Rodney A Appell

Ther Clin Risk Manag. 2006 March; 2(1): 19–24. Published online 2006 March.

PMCID: PMC1661647

| Abstract | Full Text | PDF–71K |

Ciclesonide for the treatment of asthma

Ronald Dahl

Ther Clin Risk Manag. 2006 March; 2(1): 25–38. Published online 2006 March.

PMCID: PMC1661651

| Abstract | Full Text | PDF–157K |

Antihepatitis C virus therapy in liver transplanted patients

Antonino Picciotto

Ther Clin Risk Manag. 2006 March; 2(1): 39–44. Published online 2006 March.

PMCID: PMC1661645

| Abstract | Full Text | PDF–215K |

Etoricoxib for arthritis and pain management

Peter Brooks and Paul Kubler

Ther Clin Risk Manag. 2006 March; 2(1): 45–57. Published online 2006 March.

PMCID: PMC1661646

| Abstract | Full Text | PDF–159K |

Telithromycin in the treatment of acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia

George G Zhanel, Tamiko Hisanaga, Aleksandra Wierzbowski, and Daryl J Hoban

Ther Clin Risk Manag. 2006 March; 2(1): 59–75. Published online 2006 March.

PMCID: PMC1661642

| Abstract | Full Text | PDF–194K |

Differences between the bisphosphonates for the prevention and treatment of osteoporosis

Andrew Grey and Ian R Reid

Ther Clin Risk Manag. 2006 March; 2(1): 77–86. Published online 2006 March.

PMCID: PMC1661643

| Abstract | Full Text | PDF–82K |

Renal cell carcinoma and the use of sorafenib

James MG Larkin and Tim Eisen

Ther Clin Risk Manag. 2006 March; 2(1): 87–98. Published online 2006 March.

PMCID: PMC1661649

| Abstract | Full Text | PDF–468K |

Percutaneous dermal drug delivery for local pain control

Sujatha Tadicherla and Brian Berman

Ther Clin Risk Manag. 2006 March; 2(1): 99–113. Published online 2006 March.

PMCID: PMC1661648

| Abstract | Full Text | PDF–148K |

Transdermal buprenorphine in the management of persistent pain – safety aspects

Rudolf Likar

Ther Clin Risk Manag. 2006 March; 2(1): 115–125. Published online 2006 March.

PMCID: PMC1661652

| Abstract | Full Text | PDF–97K |

Other Issues: previous | next | latest | archive

		Other Issues: previous \| next \| latest \| archive Volume 2(1); March 2006 Editorial Foreword EDITORIAL FOREWORD Garry Walsh Ther Clin Risk Manag. 2006 March; 2(1): 1–2. Published online 2006 March. PMCID: PMC1661650 \| Full Text \| PDF–33K \| Reviews Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis Frieder Bauss and Ralph C Schimmer Ther Clin Risk Manag. 2006 March; 2(1): 3–18. Published online 2006 March. PMCID: PMC1661644 \| Abstract \| Full Text \| PDF–182K \| Oxybutynin: an overview of the available formulations Rebecca J McCrery and Rodney A Appell Ther Clin Risk Manag. 2006 March; 2(1): 19–24. Published online 2006 March. PMCID: PMC1661647 \| Abstract \| Full Text \| PDF–71K \| Ciclesonide for the treatment of asthma Ronald Dahl Ther Clin Risk Manag. 2006 March; 2(1): 25–38. Published online 2006 March. PMCID: PMC1661651 \| Abstract \| Full Text \| PDF–157K \| Antihepatitis C virus therapy in liver transplanted patients Antonino Picciotto Ther Clin Risk Manag. 2006 March; 2(1): 39–44. Published online 2006 March. PMCID: PMC1661645 \| Abstract \| Full Text \| PDF–215K \| Etoricoxib for arthritis and pain management Peter Brooks and Paul Kubler Ther Clin Risk Manag. 2006 March; 2(1): 45–57. Published online 2006 March. PMCID: PMC1661646 \| Abstract \| Full Text \| PDF–159K \| Telithromycin in the treatment of acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia George G Zhanel, Tamiko Hisanaga, Aleksandra Wierzbowski, and Daryl J Hoban Ther Clin Risk Manag. 2006 March; 2(1): 59–75. Published online 2006 March. PMCID: PMC1661642 \| Abstract \| Full Text \| PDF–194K \| Differences between the bisphosphonates for the prevention and treatment of osteoporosis Andrew Grey and Ian R Reid Ther Clin Risk Manag. 2006 March; 2(1): 77–86. Published online 2006 March. PMCID: PMC1661643 \| Abstract \| Full Text \| PDF–82K \| Renal cell carcinoma and the use of sorafenib James MG Larkin and Tim Eisen Ther Clin Risk Manag. 2006 March; 2(1): 87–98. Published online 2006 March. PMCID: PMC1661649 \| Abstract \| Full Text \| PDF–468K \| Percutaneous dermal drug delivery for local pain control Sujatha Tadicherla and Brian Berman Ther Clin Risk Manag. 2006 March; 2(1): 99–113. Published online 2006 March. PMCID: PMC1661648 \| Abstract \| Full Text \| PDF–148K \| Transdermal buprenorphine in the management of persistent pain – safety aspects Rudolf Likar Ther Clin Risk Manag. 2006 March; 2(1): 115–125. Published online 2006 March. PMCID: PMC1661652 \| Abstract \| Full Text \| PDF–97K \|
		Other Issues: previous \| next \| latest \| archive
		Articles from Therapeutics and Clinical Risk Management are provided here courtesy of Dove Press Write to PMC \| PMC Home \| PubMed NCBI \| U.S. National Library of Medicine NIH \| Department of Health and Human Services Privacy Policy \| Disclaimer \| Freedom of Information Act